BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1372 related articles for article (PubMed ID: 8652455)

  • 1. Prevention and management of complications associated with the hydroxyapatite implant.
    Kaltreider SA; Newman SA
    Ophthalmic Plast Reconstr Surg; 1996 Mar; 12(1):18-31. PubMed ID: 8652455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyapatite orbital implant in children following enucleation: analysis of 531 sockets.
    Shah SU; Shields CL; Lally SE; Shields JA
    Ophthalmic Plast Reconstr Surg; 2015; 31(2):108-14. PubMed ID: 24896774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of exposed hydroxyapatite orbital implants.
    Kim YD; Goldberg RA; Shorr N; Steinsapir KD
    Ophthalmology; 1994 Oct; 101(10):1709-15. PubMed ID: 7936570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of natural hydroxyapatite implants covered with Vicryl® mesh in a series of 704 enucleations].
    Ricaud X; Levy-Gabriel C; Lumbroso-Le Rouic L; Cassoux N; Esteve M; Plancher C; Asselain B; Desjardins L
    J Fr Ophtalmol; 2014 Feb; 37(2):99-106. PubMed ID: 24210936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of complications of the hydroxyapatite orbital implant in 250 consecutive cases.
    Shields CL; Shields JA; De Potter P; Singh AD
    Trans Am Ophthalmol Soc; 1993; 91():177-89; discussion 189-95. PubMed ID: 8140690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure of orbital implants wrapped with polyester-urethane after enucleation for advanced retinoblastoma.
    Heimann H; Bechrakis NE; Zepeda LC; Coupland SE; Hellmich M; Foerster MH
    Ophthalmic Plast Reconstr Surg; 2005 Mar; 21(2):123-8. PubMed ID: 15778666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyapatite orbital implant after enucleation--experience with 200 cases.
    Shields JA; Shields CL; De Potter P
    Mayo Clin Proc; 1993 Dec; 68(12):1191-5. PubMed ID: 8246621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases.
    Yoon JS; Lew H; Kim SJ; Lee SY
    Ophthalmology; 2008 Mar; 115(3):566-572.e2. PubMed ID: 17854900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bovine pericardium versus homologous sclera as a wrapping for hydroxyapatite orbital implants.
    Arat YO; Shetlar DJ; Boniuk M
    Ophthalmic Plast Reconstr Surg; 2003 May; 19(3):189-93. PubMed ID: 12918552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital implants in retinoblastoma patients: 23 years of experience and a review of the literature.
    Mourits DL; Moll AC; Bosscha MI; Tan HS; Hartong DT
    Acta Ophthalmol; 2016 Mar; 94(2):165-74. PubMed ID: 26603132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyapatite orbital implants. Experience with 100 cases.
    McNab A
    Aust N Z J Ophthalmol; 1995 May; 23(2):117-23. PubMed ID: 7546686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the hydroxyapatite ocular implant in the pediatric population.
    De Potter P; Shields CL; Shields JA; Singh AD
    Arch Ophthalmol; 1994 Feb; 112(2):208-12. PubMed ID: 8311774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scleral wrap increases the long-term complication risk of bone-derived hydroxyapatite orbital implants.
    Toh T; Bevin TH; Molteno AC
    Clin Exp Ophthalmol; 2008 Nov; 36(8):756-61. PubMed ID: 19128381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of primary orbital implants in postenucleation retinoblastoma patients.
    Lee V; Subak-Sharpe I; Hungerford JL; Davies NP; Logani S
    Ophthalmology; 2000 May; 107(5):940-5; discussion 946. PubMed ID: 10811087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coralline hydroxyapatite spheres as secondary orbital implants in anophthalmos.
    Massry GG; Holds JB
    Ophthalmology; 1995 Jan; 102(1):161-6. PubMed ID: 7831032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical study of the hydroxyapatite orbital implant.
    Ashworth JL; Rhatigan M; Brammar R; Sunderland S; Leatherbarrow B
    Eur J Ophthalmol; 1997; 7(1):1-8. PubMed ID: 9101187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with the polymer-coated hydroxyapatite implant after enucleation in 126 patients.
    Shields CL; Uysal Y; Marr BP; Lally SE; Rodriques E; Kharod B; Shields JA
    Ophthalmology; 2007 Feb; 114(2):367-73. PubMed ID: 17270685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue breakdown and exposure associated with orbital hydroxyapatite implants.
    Buettner H; Bartley GB
    Am J Ophthalmol; 1992 Jun; 113(6):669-73. PubMed ID: 1317993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enucleation technique for children with retinoblastoma.
    Shields JA; Shields CL; De Potter P
    J Pediatr Ophthalmol Strabismus; 1992; 29(4):213-5. PubMed ID: 1324985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of artificial eye amplitudes with acrylic and hydroxyapatite spherical enucleation implants.
    Colen TP; Paridaens DA; Lemij HG; Mourits MP; van Den Bosch WA
    Ophthalmology; 2000 Oct; 107(10):1889-94. PubMed ID: 11013194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.